Getinge B stock slips after Nordea rating downgrade
Published on 09/10/2026 at 23:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Getinge AB (publ) B stock (ISIN SE0000202624) came under pressure on Nasdaq Stockholm around September 9, 2026 after a rating downgrade from Nordea pushed the shares lower by about 1.6 percent, adding a new caution signal for healthcare investors.
Nordea cuts Getinge to hold
According to EFN on September 9, 2026, Getinge B fell 1.6 percent after Nordea lowered its recommendation on the stock to hold from buy, signaling a more cautious stance on the Swedish medtech group.
A separate market update from EFN on September 10, 2026 noted that Getinge was down about 1.3 percent in early trading as the downgrade continued to weigh on sentiment.
Price moves within the 52-week range
Recent coverage indicated that Getinge B traded on Nasdaq Stockholm in Swedish krona on September 9, 2026 within its documented 52-week range, with the closing level described as stable relative to recent sessions, although still below the upper end of that range.
That roughly 1.6 percent decline around the time of Nordea's downgrade highlights how quickly rating changes can translate into price moves, even when the shares remain comfortably inside their 52-week band instead of testing either extreme.
Stock closes steady as of September 9, 2026
As of the last completed trading day, September 9, 2026, Getinge B stock closed on Nasdaq Stockholm at a level within its 52-week high and low and finished the session with only a modest variation versus the prior close, underscoring that the downgrade triggered a noticeable but not dramatic adjustment.
Getinge B stock key data
- Company: Getinge AB (publ)
- ISIN: SE0000202624
- Ticker: GETI B
- Trading venue: Nasdaq Stockholm
- Sector / Industry: Health Care Equipment
- Index membership: OMX Stockholm
